Small Cell Lung Cancer 2025 x Dr. Stephen Liu Part 1
Two Onc Docs
00:00
Breakthrough Findings from the Adriatic Study on Immunotherapy in Small Cell Lung Cancer
This chapter explores key updates from the Adriatic study, highlighting the role of immunotherapy in extensive stage small cell lung cancer. It details the study's design comparing standard treatment with Dervalimab, showcasing promising findings in progression-free and overall survival rates that may enhance clinical practices.
Transcript
Play full episode
